PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Processa Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.73+0.04 (+2.37%)
Close on Oct 19, 2026
- Market cap
- $4.76M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$5.92 (−77.39%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $4.76M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$13.56M
- EPS, diluted
- -$10.36
- Book value per share
- -$0.12
- Diluted shares
- 3M
Fifteen years at a glance
Fiscal years 2011 to 2025, USD
Revenue
–
Gross profit
–
Operating income
-$13.99M
Net income
-$13.56M
EPS, diluted
-$10.36
Free cash flow
–
Reported period